AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2013
Nov 12, 2013
30339_dirs_2013-11-12_69e50267-3b03-4ca2-b11a-2f00b4dd9d8c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2013-11-08
Reporting Person: Paproski John E (President-Delivery Systems)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-11-08 | Common Stock | A | 11.3700 | $46.7000 | Acquired | 14859.3444 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 62777.4206 | Direct |
| Common Stock | 1335.8302 | Indirect |
Footnotes
F1: Reflects additional shares purchased through dividend reinvestments based on most recent plan statement.
More from WEST PHARMACEUTICAL SERVICES INC
Board/Management Information
2026
Jun 1
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Declaration of Voting Results & Voting Rights Announcements
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Earnings Release
2026
Apr 23
Major Shareholding Notification
2026
Mar 27